Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.69 USD | +2.69% | +5.95% | +17.09% |
May. 09 | Transcript : Phathom Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
May. 09 | Phathom Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Evolution of the average Target Price on Phathom Pharmaceuticals, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Phathom Pharmaceuticals, Inc.
Stifel Nicolaus | |
Needham & Co. | |
Goldman Sachs | |
HC Wainwright | |
Craig-Hallum | |
BMO Capital | |
Guggenheim | |
Jefferies & Co. |
EPS Revisions
- Stock Market
- Equities
- PHAT Stock
- Consensus Phathom Pharmaceuticals, Inc.